R A'Hern

Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.

S Michiels, B Asselain, J Bogaerts, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

The prognostic significance of allelic imbalance at key chromosomal loci in oral cancer

R. A’Hern, G. Emilion, J. Langdon, 1999, British Journal of Cancer.

Outcome of treatment for limb and limb girdle sarcomas at the Royal Marsden Hospital.

J M Thomas, R. Ramanathan, J. Thomas, 2000, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Allelic imbalance at chromosomal loci implicated in the pathogenesis of oral precancer, cumulative loss and its relationship with progression to cancer.

R. A’Hern, G. Emilion, J. Langdon, 1998, Oral oncology.

A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer.

P. Stone, R. A’Hern, J. Hardy, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience.

D. Dearnaley, C. Parker, J. Bono, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Using an interactive video disk in breast cancer patient support.

M Baum, M. Baum, R. A’Hern, 1998, Nursing times.